December - 2016

top of page

Sage Group News

Sage Represents Mateon Therapeutics - Leadership in Novel Vascular Targeted Therapy

Sage is representing Mateon Therapeutics, a US-based biopharma company focusing on Vascular Disrupting Agents (VDAs) for orphan oncology...

bottom of page